• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform

    Diagnostic Desperation: A Look at IVD Trends During COVID-19

    Resourceful Resources: Materials Make a Difference During the Pandemic

    Stressed Testing: Challenges with Medical Device Testing
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    EchoNous Expands Its Kosmos Hardware Platform

    Medtronic Begins Trial to Assess Novel Ablation Tech to Treat AFib

    Europe's Cross-Border Medtech Deal Activity Rises in Q4 2020

    Bio-Techne to Acquire Asuragen for $320M

    QUANTA Appoints Chief Operating Officer
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform

    Diagnostic Desperation: A Look at IVD Trends During COVID-19

    Resourceful Resources: Materials Make a Difference During the Pandemic

    Stressed Testing: Challenges with Medical Device Testing
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cybersecurity Compromises, Courtesy of COVID-19

    A Look at the Actual Device Costs for Hospitals

    Show Time: Here’s What a Year of No Tradeshows Meant for Small Businesses

    FDA Making Progress With Technology and Data Action Plans

    What’s Hot Now in Medtech M&A
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Spectrum Plastics Group

    Qosina Corp.

    MW Life Sciences

    maxon

    Creganna Medical, part of TE Connectivity
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Grant Funding Works and How It Can Help

    Refurbished Medical Equipment Testing and Certification Under the NEC

    Taking the First Step with Metal Components

    4 Trends Driving Medical Manufacturing in 2021

    Pioneering AI Solutions to Reinforce Healthcare Services
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Creganna Medical, part of TE Connectivity

    PTI Engineered Plastics Inc.

    Concise Engineering

    MW Life Sciences

    Medbio LLC
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Theranos’ Holmes and Former President Balwani Charged with Massive Fraud

    Holmes stripped of control of company for defrauding investors.

    Theranos’ Holmes and Former President Balwani Charged with Massive Fraud
    Theranos CEO Elizabeth Holmes at her 2014 TEDMED presentation.
    Related CONTENT
    • Quidel's QuickVue At-Home COVID-19 Test Earns EUA
    • Hologic Buys Molecular Dx Firm Diagenode for $159M
    • Solid Growth Forecast for Japan's MI Neurosurgical Devices Market
    • South Korean HIV Testing to Reach Peak Market Value This Year
    • FDA Appoints its First Cybersecurity Director
    U.S. Securities and Exchange Commission03.14.18
    The Securities and Exchange Commission today charged Silicon Valley-based private company Theranos Inc., its founder and CEO Elizabeth Holmes, and its former President Ramesh “Sunny” Balwani with raising more than $700 million from investors through an elaborate, years-long fraud in which they exaggerated or made false statements about the company’s technology, business, and financial performance. Theranos and Holmes have agreed to resolve the charges against them. Importantly, in addition to a penalty, Holmes has agreed to give up majority voting control over the company, as well as to a reduction of her equity which, combined with shares she previously returned, materially reduces her equity stake.
     
    The complaints allege that Theranos, Holmes, and Balwani made numerous false and misleading statements in investor presentations, product demonstrations, and media articles by which they deceived investors into believing that its key product—a portable blood analyzer—could conduct comprehensive blood tests from finger drops of blood, revolutionizing the blood testing industry. In truth, according to the SEC’s complaint, Theranos’ proprietary analyzer could complete only a small number of tests, and the company conducted the vast majority of patient tests on modified and industry-standard commercial analyzers manufactured by others.
     
    The complaints further charge that Theranos, Holmes, and Balwani claimed that Theranos’ products were deployed by the U.S. Department of Defense on the battlefield in Afghanistan and on medevac helicopters and that the company would generate more than $100 million in revenue in 2014. In truth, Theranos’ technology was never deployed by the U.S. Department of Defense and generated a little more than $100,000 in revenue from operations in 2014.
     
    “Investors are entitled to nothing less than complete truth and candor from companies and their executives,” said Steven Peikin, co-director of the SEC’s Enforcement Division. “The charges against Theranos, Holmes, and Balwani make clear that there is no exemption from the anti-fraud provisions of the federal securities laws simply because a company is non-public, development-stage, or the subject of exuberant media attention.”
     
    “As a result of Holmes’ alleged fraudulent conduct, she is being stripped of control of the company she founded, is returning millions of shares to Theranos, and is barred from serving as an officer or director of a public company for 10 years,” said Stephanie Avakian, co-director of the SEC’s Enforcement Division. “This package of remedies exemplifies our efforts to impose tailored and meaningful sanctions that directly address the unlawful behavior charged and best remedies the harm done to shareholders.”
     
    “The Theranos story is an important lesson for Silicon Valley,” said Jina Choi, director of the SEC’s San Francisco Regional Office. “Innovators who seek to revolutionize and disrupt an industry must tell investors the truth about what their technology can do today, not just what they hope it might do someday.”
     
    Theranos and Holmes have agreed to settle the fraud charges levied against them. Holmes agreed to pay a $500,000 penalty, be barred from serving as an officer or director of a public company for 10 years, return the remaining 18.9 million shares that she obtained during the fraud, and relinquish her voting control of Theranos by converting her super-majority Theranos Class B Common shares to Class A Common shares. Due to the company’s liquidation preference, if Theranos is acquired or is otherwise liquidated, Holmes would not profit from her ownership until—assuming redemption of certain warrants—over $750 million is returned to defrauded investors and other preferred shareholders. The settlements with Theranos and Holmes are subject to court approval. Theranos and Holmes neither admitted nor denied the allegations in the SEC’s complaint. The SEC will litigate its claims against Balwani in federal district court in the Northern District of California.
     
    The SEC’s investigation was conducted by Jessica Chan, Rahul Kolhatkar, and Michael Foley and supervised by Monique Winkler and Erin Schneider in the San Francisco Regional Office. The SEC’s litigation will be led by Jason Habermeyer and Marc Katz of the San Francisco office.
    Related Searches
    • ceo
    • standard
    • technology
    • testing
    Related Knowledge Center
    • Diagnostics
    Suggested For You
    Quidel Quidel's QuickVue At-Home COVID-19 Test Earns EUA
    Hologic Buys Molecular Dx Firm Diagenode for $159M Hologic Buys Molecular Dx Firm Diagenode for $159M
    Solid Growth Forecast for Japan Solid Growth Forecast for Japan's MI Neurosurgical Devices Market
    South Korean HIV Testing to Reach Peak Market Value This Year South Korean HIV Testing to Reach Peak Market Value This Year
    FDA Appoints its First Cybersecurity Director FDA Appoints its First Cybersecurity Director
    Pioneering AI Solutions to Reinforce Healthcare Services Pioneering AI Solutions to Reinforce Healthcare Services
    BD Earns EUA, CE Mark for Combo SARS-CoV-2, Influenza A+B Test BD Earns EUA, CE Mark for Combo SARS-CoV-2, Influenza A+B Test
    Refurbished Medical Imaging Equipment Market to be Worth $21.14 Billion By 2027 Refurbished Medical Imaging Equipment Market to be Worth $21.14 Billion By 2027
    Evolving Trends in the Medical and Orthopedic Devices Industry Evolving Trends in the Medical and Orthopedic Devices Industry
    SmartBreast Corp. Acquires Discover NM750b from GE Healthcare SmartBreast Corp. Acquires Discover NM750b from GE Healthcare
    Rapid Medical Diagnostic Kits Market Size Worth $23.04 Billion By 2027 Rapid Medical Diagnostic Kits Market Size Worth $23.04 Billion By 2027
    Avacta Group and Mologic Enter Commercial Partnership Avacta Group and Mologic Enter Commercial Partnership
    Element Material Technology Acquires Avomeen Element Material Technology Acquires Avomeen
    India India's NIPT Testing Market Driven by Demand for Non-Invasive Genetic Assessments
    High-Volume COVID Antigen Test Receives FDA EUA High-Volume COVID Antigen Test Receives FDA EUA

    Related Breaking News

    • Diagnostics
      EchoNous Expands Its Kosmos Hardware Platform

      EchoNous Expands Its Kosmos Hardware Platform

      Adds continuous wave and pulsed wave Doppler capabilities.
      Charles Sternberg, Assistant Editor 03.04.21

    • Chronic Disease | Diagnostics
      Bio-Techne to Acquire Asuragen for $320M

      Bio-Techne to Acquire Asuragen for $320M

      Bio-Techne gains genetic carrier screening and oncology testing kits.
      Sam Brusco, Associate Editor 03.04.21

    • Diagnostics | Digital Health
      Philips, Disney Join Forces to Reduce Childrens

      Philips, Disney Join Forces to Reduce Childrens' MRI Anxiety

      Will explore effects and use of animated stories and characters, including Disney favorites, as part of Philips Ambient Experience solution.
      Sam Brusco, Associate Editor 03.03.21


    • Diagnostics
      Quidel

      Quidel's QuickVue At-Home COVID-19 Test Earns EUA

      Easy-to-use at-home test provides results in ten minutes with a doctor’s prescription.
      Sam Brusco, Associate Editor 03.02.21

    • Diagnostics
      Hologic Buys Molecular Dx Firm Diagenode for $159M

      Hologic Buys Molecular Dx Firm Diagenode for $159M

      Diagenode brings more than 30 CE-marked, real-time PCR tests.
      Sam Brusco, Associate Editor 03.02.21

    • Diagnostics
      SpinTech Inc. Acquires MR Innovations

      SpinTech Inc. Acquires MR Innovations

      Includes an expert team of engineers and physicists and MR Innovations' patents, published papers and network of global collaborators.
      Charles Sternberg, Assistant Editor 02.24.21


    • Diagnostics
      Rice University Researchers Receive Funding to Develop Covid-19 Sensor System

      Rice University Researchers Receive Funding to Develop Covid-19 Sensor System

      Real-time electronic system will be able to detect minute amounts of SARS-CoV-2.
      Charles Sternberg, Assistant Editor 02.22.21

    • Diagnostics
      BD Collaborates with Scanwell Health

      BD Collaborates with Scanwell Health

      Aims to create an at-home rapid test for SARS-CoV-2 using a BD antigen test and the Scanwell Health mobile app.
      Charles Sternberg, Assistant Editor 02.22.21

    • Diagnostics
      Study Validates Vocalis Health’s COVID-19 Screening Tool

      Study Validates Vocalis Health’s COVID-19 Screening Tool

      VocalisCheck obtains CE mark approval for medical use.
      Charles Sternberg, Assistant Editor 02.18.21


    • Diagnostics
      Test Identifies COVID-19 Patients at Increased Risk of Intubation With Mechanical Ventilation

      Test Identifies COVID-19 Patients at Increased Risk of Intubation With Mechanical Ventilation

      The assay is currently available in Europe.
      Michael Barbella, Managing Editor 02.16.21

    • Diagnostics
      FDA Grants EUA to Bio-Rad Reliance Assay Kits

      FDA Grants EUA to Bio-Rad Reliance Assay Kits

      Help physicians more easily detect and differentiate SARS-CoV-2 in patients.
      Charles Sternberg, Assistant Editor 02.16.21

    • Diagnostics
      Suitcase Laboratory to Detect COVID-19 in Development

      Suitcase Laboratory to Detect COVID-19 in Development

      Mobile laboratory for rapid detection of SARS-CoV-2 for Africa.
      Sam Brusco, Associate Editor 02.12.21


    • Diagnostics
      BD Earns EUA, CE Mark for Combo SARS-CoV-2, Influenza A+B Test

      BD Earns EUA, CE Mark for Combo SARS-CoV-2, Influenza A+B Test

      Also shows ability to detect U.K., South African variants of COVID-19.
      Sam Brusco, Associate Editor 02.12.21

    • Diagnostics
      ProPhase Labs Begins Saliva-Based, Viral RT-PCR Multiplex-Testing

      ProPhase Labs Begins Saliva-Based, Viral RT-PCR Multiplex-Testing

      System can be used for COVID-19, Influenza A & B, and other viruses.
      Charles Sternberg, Assistant Editor 02.09.21

    • Diagnostics
      SmartBreast Corp. Acquires Discover NM750b from GE Healthcare

      SmartBreast Corp. Acquires Discover NM750b from GE Healthcare

      Will manufacture, market, and distribute the Molecular Breast Imaging scanner.
      Charles Sternberg, Assistant Editor 02.09.21


    Trending
    • FDA Breakthrough Device Designation Awarded To BrainCool AB's Cooral System
    • Philips, Disney Join Forces To Reduce Childrens' MRI Anxiety
    • Mike On Medtech: Update On FDA's STeP Designation
    • Plastikos Medical Begins Phase II Of Expansion
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    Breaking News
    • EchoNous Expands Its Kosmos Hardware Platform
    • Medtronic Begins Trial to Assess Novel Ablation Tech to Treat AFib
    • Europe's Cross-Border Medtech Deal Activity Rises in Q4 2020
    • Bio-Techne to Acquire Asuragen for $320M
    • QUANTA Appoints Chief Operating Officer
    View Breaking News >
    CURRENT ISSUE

    March 2021

      View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    IFT Transitions 2021 Annual Event to Digital Experience
    NY Federal Judge Enters Permanent Injunction Against Dietary Supplement Manufacturer
    Statins May Contribute to Vascular Calcification by Inhibiting Vitamin K-Dependent Proteins
    Coatings World

    Latest Breaking News From Coatings World

    Chromaflo Technologies Adds Benjamin Woeste as Territory Sales Manager
    Maroon Group Acquires Cary Company's Raw Materials, Specialty Chemicals Distribution Business
    Matt Fogel Named Mule-Hide's Territory Manager – Southern Virginia
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    EchoNous Expands Its Kosmos Hardware Platform
    Medtronic Begins Trial to Assess Novel Ablation Tech to Treat AFib
    Europe's Cross-Border Medtech Deal Activity Rises in Q4 2020
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Amgen to Acquire Five Prime Therapeutics for $1.9B
    Genesis Drug Discovery & Development Acquires Integrated Analytical Solutions
    CureVac, Novartis Ink COVID Vax Mfg. Pact
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Estée Lauder Establishes Equity and Engagement Center of Excellence
    L'Oreal On How It Will Shape Beauty's Future at Today's Transparency Summit
    C.O. Bigelow Earns Praise as NYC's Oldest Family-Run Apothecary
    Happi

    Latest Breaking News From Happi

    Avon Launches Vegan Skin Care Line
    Inolex Appoints VP Marketing
    Decorté Launches AI Diagnostics in US
    Ink World

    Latest Breaking News From Ink World

    Massilly North America Adds Koenig & Bauer MetalStar 3 Metal Decorating Press
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Henkel publishes 30th Sustainability Report
    Avery Dennison Smartrac launches new Circus Pro inlays
    Springfield Solutions highlights digital label embellishments
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    FPInnovations Develops Biodegradable Mask
    Sani Professional Sanitizing and Disinfecting Products Approved by EPA
    Autefa Solutions Offers Fully Automated Line for Protective Mask Production
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Bioventus Appoints Managing Director, China and Asia Pacific
    Full-Year Sales Down 12 Percent at Zimmer Biomet
    Lincotek Medical Expands Coatings and Additive Capacity
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login